Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2008
01/10/2008WO2007092583A3 Functionalizing implantable devices with a poly (diol-co-citrate) polymer
01/10/2008WO2007027947A3 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport
01/10/2008WO2007022478A3 Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death
01/10/2008WO2006101830A3 Hemipteran glutamate ligand gated ion channel
01/10/2008WO2006091766A3 Human trophoblast stem cells and use thereof
01/10/2008WO2006090750A8 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
01/10/2008WO2006044864A3 Vaccine adjuvant
01/10/2008US20080010704 Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby
01/10/2008US20080010703 Yield and stress tolerance in transgenic plants
01/10/2008US20080010701 polynucleotides encoding polypeptides active in fructan, cellulose, starch and/or tannin biosynthetic pathways; transgenic plant cells
01/10/2008US20080010698 Expansin Polypeptides
01/10/2008US20080010694 Method of acquiring immunological tolerance
01/10/2008US20080010693 Human coagulation factor VII polypeptides
01/10/2008US20080010692 Mammals carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
01/10/2008US20080010026 Gene sequence of L-rhamnose isomerase having new catalytic function and use thereof
01/10/2008US20080009942 Method for in situ repair of injured, damaged, diseased or aged articular cartilage
01/10/2008US20080009609 Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
01/10/2008US20080009508 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
01/10/2008US20080009489 Androgen receptor modulators and method of treating disease using the same
01/10/2008US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion
01/10/2008US20080009458 medical diagnosis of cancer comprising detecting constitutive photomorphogenic 1(COP1) molecule in a sample of the cancer, wherein gene overexpression of the (COP1) molecule relative to a control is indicative of cancer
01/10/2008US20080009457 Reaction of Rna and cochleate
01/10/2008US20080009446 Recombinant human albumin fusion proteins with long-lasting biological effects
01/10/2008US20080009077 antibody against a soluble fibrin, which does not react with fibrinogen but specifically recognizes a conformation-changed site newly occurred in a C-terminal region of an A alpha -chain of the soluble fibrin formed through thrombin digestion of fibrinogen; disseminated intravascular coagulation
01/10/2008US20080009066 Plant gene encoding trehalose metabolism enzymes
01/10/2008US20080009065 Genes encoding insect odorant receptors and uses thereof
01/10/2008US20080009064 Temperature-Responsive Microcarrier
01/10/2008US20080009063 Substrate for cell culture
01/10/2008US20080009061 Method for preserving pancreatic islet, container for preserving pancreatic islet, and kit for transplanting pancreatic islet
01/10/2008US20080009060 Methods of discovering chemicals capable of functioning as gene expression modulators
01/10/2008US20080009059 Method for growing adult cells
01/10/2008US20080009058 Chimeric IgE Polypeptides and Host Cells
01/10/2008US20080009057 Using cell surface antigen profile as tool to recover preferential liver tissues; liver development and regeneration
01/10/2008US20080009056 Polypeptide, cDNA encoding the same and use of them
01/10/2008US20080009053 Modified Ethylenediamine-N, N'-Disuccinate: Ethylnediamine Lyase
01/10/2008US20080009032 Method for Producing Yellow Flower by Controlling Flavonoid Synthetic Pathway
01/10/2008US20080009031 Mutant cells with altered sialic acid
01/10/2008US20080009027 Enhanced Oxygen Cell Culture Platforms
01/10/2008US20080009025 Protein kinase regulation
01/10/2008US20080009016 Novel Monkey Gpr103 and Monkey Qrfp and Method of Evaluating Compound By Using Gpr103
01/10/2008US20080009014 Receptor activator of NF-kappaB
01/10/2008US20080009008 Composition and method for treating lupus nephritis
01/10/2008US20080009004 Claudin polypeptides, polynucleotides, and methods of making and use thereof
01/10/2008US20080008992 Method Of Pretreating Specimen And Immunoassay Using The Same
01/10/2008US20080008737 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject
01/10/2008US20080008715 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy
01/10/2008US20080008713 Tumor Necrosis Factor Receptor I (TNFR1); immunoglobulins; competitive binding; inhibiting signal transduction; pharmacokinetics; storage stability
01/10/2008US20080008706 B7S1: an immune modulator
01/10/2008US20080008701 C-met receptor regulation by angiotensin iv (at4) receptor ligands
01/10/2008US20080008700 Multimeric Fc Receptor Polypeptides
01/10/2008US20080008693 Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use
01/10/2008US20080008689 Method for Transdifferentiation of Non Pancreatic Stem Cells to the Pancreatic Differentiation Pathway
01/10/2008US20080008687 Transposon-Based Targeting System
01/10/2008US20080008684 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
01/10/2008US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins
01/10/2008US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings
01/10/2008US20080008680 pure mutant Interleukin-15 polypeptide; immunosuppressant; immunotherapy
01/10/2008US20080008653 Models for vaccine assessment
01/10/2008DE102006031483A1 Zellulärer Pyrogentest Cellular pyrogen
01/10/2008CA2691346A1 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells
01/10/2008CA2658060A1 Erythropoietin-producing organoid precursor, production method thereof, and method for treating erythropoietin-related disorder
01/10/2008CA2657232A1 Enhanced oxygen cell culture platforms
01/10/2008CA2657013A1 Temperature-responsive microcarrier
01/10/2008CA2656884A1 Cellular pyrogen test
01/10/2008CA2656771A1 Small streptococcus pyogenes antigens and their use
01/10/2008CA2653546A1 Bio-membrane for tissue regeneration
01/09/2008EP1876445A1 Antibody directed against gastrin-releasing peptide precursor and use thereof
01/09/2008EP1876238A1 Novel polypeptide and use thereof
01/09/2008EP1876235A1 Novel pantothenate kinase gene and use thereof
01/09/2008EP1876233A1 Cells capable of differentiating into cardiac muscle cells
01/09/2008EP1876185A1 An antibody which recognizes phosphorylated polypeptides
01/09/2008EP1875927A1 Methods for evaluating a compound for its effect on skin
01/09/2008EP1875924A2 RGD-enriched gelatine-like proteins with enhanced cell binding
01/09/2008EP1875922A2 Intestinal trefoil proteins
01/09/2008EP1874940A1 Transfection of collagen-producing cells
01/09/2008EP1874939A1 Directed complementation
01/09/2008EP1874922A2 Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
01/09/2008EP1874921A1 Transplantation of differentiated immature adipocytes and biodegradable scaffold for tissue augmentation
01/09/2008EP1874919A1 Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
01/09/2008EP1874918A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
01/09/2008EP1874816A2 Modulation of antibody effector function by hinge domain engineering
01/09/2008EP1874794A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns
01/09/2008EP1874367A2 Biocompatible material for surgical implants and cell guiding tissue culture surfaces
01/09/2008EP1874351A2 Anti-il-6 antibodies, compositions, methods and uses
01/09/2008EP1874114A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor
01/09/2008EP1556485B1 Reversible, parallel and multitask cloning method and kit
01/09/2008EP1478793B1 Device for creating hanging drops and corresponding method
01/09/2008EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
01/09/2008EP1371664B1 Wti modified peptide
01/09/2008EP1290129B1 Redeposition or backstain inhibition during stonewashing process
01/09/2008EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia
01/09/2008EP1206558B1 Plants with modified polyunsaturated fatty acids
01/09/2008EP1135463B1 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
01/09/2008EP1129196B1 Virulence genes and proteins, and their use
01/09/2008EP1129064B1 Transfection reagents
01/09/2008EP1021552B1 Transgenic lemnaceae
01/09/2008EP0828837B1 Chimeric gene comprising a dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides
01/09/2008CN101103102A Virus recovery medium, use thereof and viral diagnostic kit including same
01/09/2008CN101103101A Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)
01/09/2008CN101103044A Anti-alhpha 9 integrin antibody and the use thereof